Franklin Resources’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.2M Buy
968,182
+505,356
+109% +$29.3M 0.02% 489
2025
Q4
$19.1M Buy
462,826
+12,515
+3% +$485K ﹤0.01% 977
2025
Q3
$17.7M Buy
+450,311
New +$11.5M ﹤0.01% 985

Other funds holding DNTH

Franklin Resources's DNTH Position: Q1 2026 in Review

Franklin Resources increased its Dianthus Therapeutics (DNTH) stake by 109% in Q1 2026, buying an estimated $29.3M and bringing the position to 968,182 shares worth $81.2M. The position accounts for 0.02% of the portfolio, ranked #489.

Franklin Resources first reported a position in DNTH in Q3 2025 and has held it in 3 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Franklin Resources held 968,182 shares of Dianthus Therapeutics worth $81.2M as of Q1 2026.
  • Franklin Resources bought 505,356 Dianthus Therapeutics shares in Q1 2026, an estimated $29.3M.
  • Dianthus Therapeutics made up 0.02% of Franklin Resources's portfolio in Q1 2026, its #489 holding.
  • Franklin Resources first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.